Home › Funds › ORBIMED ADVISORS LLC › ABVX

ORBIMED ADVISORS LLC position in ABVX

ABIVAX SA · Health Care

ORBIMED ADVISORS LLC reported holding 200,000 shares of ABVX (ABIVAX SA) in its Q2 2026 13F filing — a position valued at US$26.7M, representing 0.54% of its reported portfolio and ranking #48 among its reported holdings. ORBIMED ADVISORS LLC has disclosed ABVX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)200.00K sh
Reported value held$26.65M
Portfolio Weight0.54%
First reportedQ3 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ORBIMED ADVISORS LLC's ABVX position evolved

ORBIMED ADVISORS LLC first disclosed a stake in ABVX in Q3 2025 at 380,000 shares (US$32.3M). The position peaked in Q1 2026 at 465,700 shares, worth US$51.9M. Across 4 filings, ORBIMED ADVISORS LLC increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 200,000 shares valued at US$26.7M — a reduction of -265,700 shares quarter over quarter.. Notable position changes include a 27% increase in Q1 2026 (shares rose 20% over the following quarter), a 57% trim in Q2 2026 (shares fell 26% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2025 380.00K $32.26M New
Q4 2025 367.90K $49.61M Reduce
Q1 2026 465.70K $51.86M Add
Q2 2026 200.00K $26.65M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABVX and 13F data

ABVX (ABIVAX SA) is a Health Care company. 72 other funds we track also report a position in ABVX — the largest reported positions include TCG Crossover Management, LLC (US$800.6M), Helikon Investments Ltd (US$371.4M), Darwin Global Management, Ltd. (US$348.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABVX

All ABVX fund holders →

FAQ

How long has ORBIMED ADVISORS LLC held ABVX?

ORBIMED ADVISORS LLC has disclosed ABVX holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is ORBIMED ADVISORS LLC's current position in ABVX?

As of Q2 2026, ORBIMED ADVISORS LLC holds 200.00K shares of ABVX (ABIVAX SA), valued at $26.65M, representing 0.54% of its reported portfolio and ranking #48.

Has ORBIMED ADVISORS LLC been buying or selling ABVX?

In the latest 13F filing (Q2 2026), ORBIMED ADVISORS LLC reduced its position in ABVX. The position peaked in Q1 2026 at 465.70K shares.

Which other funds hold ABVX?

Other major institutional holders of ABVX include TCG Crossover Management, LLC, Helikon Investments Ltd, Darwin Global Management, Ltd., among 72 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.